Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham Study
Authors:
- Amanda M. ShearmanASAmanda M. Shearman
- Jose M. OrdovasJOJose M. Ordovas
- J. Dianne KeenJKJ. Dianne Keen
- Richard H. MyersRMRichard H. Myers
Open Access
- 22 May 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 9 (9) , 1315-1320
Abstract
Some studies show that plasma triglyceride (TG) levels are a significant independent risk factor for cardiovascular disease (CVD). TG levels are inversely correlated with high density lipoprotein cholesterol (HDL-C) levels, and their metabolism may be closely interrelated. Therefore, the TG/HDL-C ratio may be a relevant CVD risk factor. Our analysis of families in the Framingham Heart Study gave a genetic heritability estimate for log(TG) of 0.40 and for log(TG/HDL-C) of 0.49, demonstrating an important genetic component for both. A 10 cM genome-wide scan for log(TG) level and log(TG/HDL-C) was carried out for the largest 332 extended families of the Framingham Heart Study (1702 genotyped individuals). The highest multipoint variance component LOD scores obtained for both log(TG) and log(TG/HDL-C) were on chromosome 7 (at 155 cM), where the results for the two phenotypes were 1.8 and 2.5, respectively. The 7q32.3–qter region contains several candidate genes. Four other regions with multipoint LOD scores greater than one were identified on chromosome 3 [LOD score for log(TG/HDL-C) = 1.8 at 140 cM], chromosome 11 [LOD score for log(TG/HDL-C) = 1.1 at 125 cM], chromosome 16 [LOD score for log(TG) = 1.5 at 70 cM, LOD score for log(TG/HDL-C) = 1.1 at 75 cM] and chromosome 20 [LOD score for log(TG/HDL-C) = 1.7 at 35 cM, LOD score for log(TG) = 1.3 at 40 cM]. These results identify loci worthy of further study.Keywords
This publication has 18 references indexed in Scilit:
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyNature Genetics, 1999
- Reverse Cholesterol Transport—A Review of the Process and Its Clinical ImplicationsClinical Biochemistry, 1997
- Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway1997
- GCN20, a novel ATP binding cassette protein, and GCN1 reside in a complex that mediates activation of the eIF‐2 alpha kinase GCN2 in amino acid‐starved cells.The EMBO Journal, 1995
- Smith‐Lemli‐Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: Probable Disruption of an SLOS geneAmerican Journal of Medical Genetics, 1994
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- Dispersed family of human genes with sequence similarity to farnesyl pyrophosphate synthetaseGenomics, 1989
- Biological and cultural sources of familial resemblance in plasma lipids: A comparison between North America and Israel—the lipid research clinics programGenetic Epidemiology, 1988
- Smith‐Lemli‐Opitz syndrome‐type II: Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethalityAmerican Journal of Medical Genetics, 1987
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986